
-

Economic Model IDs Pandemic Business Opening Risks
As communities try to manage their economies during the Covid-19 pandemic, three economists offer a model to help decide which businesses to open after shutting down.
-

Covid-19 Antibody Cocktail to Begin Clinical Trial
A combination of two synthetic antibodies, with an enhanced infection-blocking design for preventing and treating Covid-19 infections, is set to begin a clinical trial.
-

Crispr Heart Disease Start-Up Raises New $63M
A one year-old company developing a one-time gene-editing treatment for coronary artery disease is adding $63 million to its first venture funding round.
-

Challenge Seeks Class of 2020 Covid-Inspired Companies
A new challenge competition aims to recognize start-up companies founded by university students getting their undergraduate degrees this year.
-

Cancer Drug Technology Licensed for Covid-19
A biotechnology company is licensing medical research discoveries from university labs first designed for treating cancer as a potential Covid-19 therapy.
-

Foundations Back ALS Biomarker Study
Two organizations supporting research on amyotrophic lateral sclerosis or ALS are funding a study of changes to chemical indicators in the body responding to ALS drugs.
-

Weak Covid-19 App Privacy Found, Risk Software in Works
An analysis of mobile apps tracking Covid-19 cases and symptoms finds most lack basic privacy protections, despite collecting personal identifying information.
-

Trial Indicates App Helps Treat Behavior Disorder
Results of a clinical trial suggest a smartphone app designed for use in a therapy program helps some people control their obsessive-compulsive disorder.
-

Covid-19 Vaccine for Lower-Income Regions Underway
Researchers in the U.K. designed a vaccine to prevent Covid-19 infections and is starting an enterprise to make it available to lower-income countries.
-

Infographic – High Hopes for Covid-19 Therapy, Vaccine
Sizeable majorities of Americans expect to see treatments and a vaccine for Covid-19 in the next 12 months, but also another outbreak of the disease.